Vonoprazan

Chemical formula: C₁₇H₁₆FN₃O₂S  Molecular mass: 345.39 g/mol  PubChem compound: 15981397

Active ingredient description

Vonoprazan suppresses basal and stimulated gastric acid secretion at the secretory surface of the gastric parietal cell through inhibition of the H+, K+-ATPase enzyme system in a potassium competitive manner. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, vonoprazan has been characterized as a type of gastric proton-pump inhibitor, in that it blocks the final step of acid production. Vonoprazan does not require activation by acid. Vonoprazan may selectively concentrate in the parietal cells in both the resting and stimulated states. Vonoprazan binds to the active pumps in a noncovalent and reversible manner.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A02BC08 A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC08

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
VOQUEZNA Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
VOCINTI Film-coated tablet Health Sciences Authority (SG) MPI, Generic

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 881681-00-1
DrugBank Drug: DB11739
PubChem Compound: 15981397
UNII Identifier: 1R5L3J156G
VONOPRAZAN

Medicines

Vonoprazan is an active ingredient of these brands:

United States (US)

Brazil (BR)

  • INZELM as VONOPRAZAN FUMARATE

Estonia (EE)

Japan (JP)

  • TAKECAB as VONOPRAZAN FUMARATE

  • (combination) CABPIRIN as VONOPRAZAN FUMARATE
  • (combination) VONOPION as VONOPRAZAN FUMARATE
  • (combination) VONOSAP as VONOPRAZAN FUMARATE

Singapore (SG)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.